List of Tables
Table 1. Global Adalimumab Monoclonal Antibody Biosimilar Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Adalimumab Monoclonal Antibody Biosimilar Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Adalimumab Monoclonal Antibody Biosimilar Market Competitive Situation by Manufacturers in 2024
Table 4. Global Adalimumab Monoclonal Antibody Biosimilar Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Adalimumab Monoclonal Antibody Biosimilar Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Adalimumab Monoclonal Antibody Biosimilar Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Adalimumab Monoclonal Antibody Biosimilar Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Adalimumab Monoclonal Antibody Biosimilar, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Adalimumab Monoclonal Antibody Biosimilar, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Adalimumab Monoclonal Antibody Biosimilar, Product Type & Application
Table 12. Global Key Manufacturers of Adalimumab Monoclonal Antibody Biosimilar, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adalimumab Monoclonal Antibody Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adalimumab Monoclonal Antibody Biosimilar as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adalimumab Monoclonal Antibody Biosimilar Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Adalimumab Monoclonal Antibody Biosimilar Sales by Region (2020-2025) & (K Units)
Table 18. Global Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Region (2020-2025)
Table 19. Global Adalimumab Monoclonal Antibody Biosimilar Sales by Region (2026-2031) & (K Units)
Table 20. Global Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Region (2026-2031)
Table 21. Global Adalimumab Monoclonal Antibody Biosimilar Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Region (2020-2025)
Table 23. Global Adalimumab Monoclonal Antibody Biosimilar Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Region (2026-2031)
Table 25. North America Adalimumab Monoclonal Antibody Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Adalimumab Monoclonal Antibody Biosimilar Sales by Country (2020-2025) & (K Units)
Table 27. North America Adalimumab Monoclonal Antibody Biosimilar Sales by Country (2026-2031) & (K Units)
Table 28. North America Adalimumab Monoclonal Antibody Biosimilar Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Adalimumab Monoclonal Antibody Biosimilar Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Adalimumab Monoclonal Antibody Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Adalimumab Monoclonal Antibody Biosimilar Sales by Country (2020-2025) & (K Units)
Table 32. Europe Adalimumab Monoclonal Antibody Biosimilar Sales by Country (2026-2031) & (K Units)
Table 33. Europe Adalimumab Monoclonal Antibody Biosimilar Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Adalimumab Monoclonal Antibody Biosimilar Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Adalimumab Monoclonal Antibody Biosimilar Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Adalimumab Monoclonal Antibody Biosimilar Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Adalimumab Monoclonal Antibody Biosimilar Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Adalimumab Monoclonal Antibody Biosimilar Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Adalimumab Monoclonal Antibody Biosimilar Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Adalimumab Monoclonal Antibody Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Adalimumab Monoclonal Antibody Biosimilar Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Adalimumab Monoclonal Antibody Biosimilar Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Adalimumab Monoclonal Antibody Biosimilar Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Adalimumab Monoclonal Antibody Biosimilar Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Adalimumab Monoclonal Antibody Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Adalimumab Monoclonal Antibody Biosimilar Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Adalimumab Monoclonal Antibody Biosimilar Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Adalimumab Monoclonal Antibody Biosimilar Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Adalimumab Monoclonal Antibody Biosimilar Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Adalimumab Monoclonal Antibody Biosimilar Sales (K Units) by Type (2020-2025)
Table 51. Global Adalimumab Monoclonal Antibody Biosimilar Sales (K Units) by Type (2026-2031)
Table 52. Global Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Type (2020-2025)
Table 53. Global Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Type (2026-2031)
Table 54. Global Adalimumab Monoclonal Antibody Biosimilar Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Adalimumab Monoclonal Antibody Biosimilar Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Type (2020-2025)
Table 57. Global Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Type (2026-2031)
Table 58. Global Adalimumab Monoclonal Antibody Biosimilar Price (US$/Unit) by Type (2020-2025)
Table 59. Global Adalimumab Monoclonal Antibody Biosimilar Price (US$/Unit) by Type (2026-2031)
Table 60. Global Adalimumab Monoclonal Antibody Biosimilar Sales (K Units) by Application (2020-2025)
Table 61. Global Adalimumab Monoclonal Antibody Biosimilar Sales (K Units) by Application (2026-2031)
Table 62. Global Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Application (2020-2025)
Table 63. Global Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Application (2026-2031)
Table 64. Global Adalimumab Monoclonal Antibody Biosimilar Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Adalimumab Monoclonal Antibody Biosimilar Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Application (2020-2025)
Table 67. Global Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Application (2026-2031)
Table 68. Global Adalimumab Monoclonal Antibody Biosimilar Price (US$/Unit) by Application (2020-2025)
Table 69. Global Adalimumab Monoclonal Antibody Biosimilar Price (US$/Unit) by Application (2026-2031)
Table 70. Cadila Healthcare Company Information
Table 71. Cadila Healthcare Description and Business Overview
Table 72. Cadila Healthcare Adalimumab Monoclonal Antibody Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Cadila Healthcare Adalimumab Monoclonal Antibody Biosimilar Product
Table 74. Cadila Healthcare Recent Developments/Updates
Table 75. Torrent Pharmaceuticals Company Information
Table 76. Torrent Pharmaceuticals Description and Business Overview
Table 77. Torrent Pharmaceuticals Adalimumab Monoclonal Antibody Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Torrent Pharmaceuticals Adalimumab Monoclonal Antibody Biosimilar Product
Table 79. Torrent Pharmaceuticals Recent Developments/Updates
Table 80. Amgen Company Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen Adalimumab Monoclonal Antibody Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Amgen Adalimumab Monoclonal Antibody Biosimilar Product
Table 84. Amgen Recent Developments/Updates
Table 85. Boehringer Ingelheim Company Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Adalimumab Monoclonal Antibody Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Boehringer Ingelheim Adalimumab Monoclonal Antibody Biosimilar Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Novartis Company Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Adalimumab Monoclonal Antibody Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Novartis Adalimumab Monoclonal Antibody Biosimilar Product
Table 94. Novartis Recent Developments/Updates
Table 95. Samsung Bioepis Company Information
Table 96. Samsung Bioepis Description and Business Overview
Table 97. Samsung Bioepis Adalimumab Monoclonal Antibody Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Samsung Bioepis Adalimumab Monoclonal Antibody Biosimilar Product
Table 99. Samsung Bioepis Recent Developments/Updates
Table 100. Viatris Company Information
Table 101. Viatris Description and Business Overview
Table 102. Viatris Adalimumab Monoclonal Antibody Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Viatris Adalimumab Monoclonal Antibody Biosimilar Product
Table 104. Viatris Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Adalimumab Monoclonal Antibody Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Pfizer Adalimumab Monoclonal Antibody Biosimilar Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Fresenius Kabi Company Information
Table 111. Fresenius Kabi Description and Business Overview
Table 112. Fresenius Kabi Adalimumab Monoclonal Antibody Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Fresenius Kabi Adalimumab Monoclonal Antibody Biosimilar Product
Table 114. Fresenius Kabi Recent Developments/Updates
Table 115. Coherus Company Information
Table 116. Coherus Description and Business Overview
Table 117. Coherus Adalimumab Monoclonal Antibody Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Coherus Adalimumab Monoclonal Antibody Biosimilar Product
Table 119. Coherus Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Adalimumab Monoclonal Antibody Biosimilar Distributors List
Table 123. Adalimumab Monoclonal Antibody Biosimilar Customers List
Table 124. Adalimumab Monoclonal Antibody Biosimilar Market Trends
Table 125. Adalimumab Monoclonal Antibody Biosimilar Market Drivers
Table 126. Adalimumab Monoclonal Antibody Biosimilar Market Challenges
Table 127. Adalimumab Monoclonal Antibody Biosimilar Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adalimumab Monoclonal Antibody Biosimilar
Figure 2. Global Adalimumab Monoclonal Antibody Biosimilar Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Adalimumab Monoclonal Antibody Biosimilar Market Share by Type: 2024 & 2031
Figure 4. Syringe Product Picture
Figure 5. Pen Product Picture
Figure 6. Global Adalimumab Monoclonal Antibody Biosimilar Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Adalimumab Monoclonal Antibody Biosimilar Market Share by Application: 2024 & 2031
Figure 8. Ankylosing Spondylitis
Figure 9. Rheumatoid Arthritis
Figure 10. Crohn’s Disease
Figure 11. Other
Figure 12. Global Adalimumab Monoclonal Antibody Biosimilar Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Adalimumab Monoclonal Antibody Biosimilar Market Size (2020-2031) & (US$ Million)
Figure 14. Global Adalimumab Monoclonal Antibody Biosimilar Sales (2020-2031) & (K Units)
Figure 15. Global Adalimumab Monoclonal Antibody Biosimilar Average Price (US$/Unit) & (2020-2031)
Figure 16. Adalimumab Monoclonal Antibody Biosimilar Report Years Considered
Figure 17. Adalimumab Monoclonal Antibody Biosimilar Sales Share by Manufacturers in 2024
Figure 18. Global Adalimumab Monoclonal Antibody Biosimilar Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Adalimumab Monoclonal Antibody Biosimilar Players: Market Share by Revenue in Adalimumab Monoclonal Antibody Biosimilar in 2024
Figure 20. Adalimumab Monoclonal Antibody Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Adalimumab Monoclonal Antibody Biosimilar Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Country (2020-2031)
Figure 23. North America Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Country (2020-2031)
Figure 24. United States Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Country (2020-2031)
Figure 27. Europe Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Country (2020-2031)
Figure 28. Germany Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Region (2020-2031)
Figure 35. China Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Country (2020-2031)
Figure 43. Latin America Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Adalimumab Monoclonal Antibody Biosimilar Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Adalimumab Monoclonal Antibody Biosimilar Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Adalimumab Monoclonal Antibody Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Adalimumab Monoclonal Antibody Biosimilar by Type (2020-2031)
Figure 53. Global Revenue Market Share of Adalimumab Monoclonal Antibody Biosimilar by Type (2020-2031)
Figure 54. Global Adalimumab Monoclonal Antibody Biosimilar Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Adalimumab Monoclonal Antibody Biosimilar by Application (2020-2031)
Figure 56. Global Revenue Market Share of Adalimumab Monoclonal Antibody Biosimilar by Application (2020-2031)
Figure 57. Global Adalimumab Monoclonal Antibody Biosimilar Price (US$/Unit) by Application (2020-2031)
Figure 58. Adalimumab Monoclonal Antibody Biosimilar Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
